Misdiagnosis of Addison's disease in a patient with end-stage renal disease

Renal Failure

Volumn 33, Issue 1, 2011, Pages 88-91

  Kocyigit, Ismail ^a   Unal, Aydin ^a   Tanriverdi, Fatih ^a   Hayri Sipahioglu, Murat ^a   Tokgoz, Bulent ^a   Oymak, Oktay ^a   Utas, Cengiz ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Addison's disease; Dialysis; Hyperpigmentation; Hypoglycemia

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CALCIUM ACETATE; CORTICOTROPIN; HYDROCORTISONE; LANSOPRAZOLE; PREDNISOLONE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN;

ADDISON DISEASE; ADULT; ANEMIA; ANTIBODY TITER; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; HEMODIALYSIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOGLYCEMIA; KIDNEY FAILURE; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL;

ADDISON DISEASE; DIAGNOSTIC ERRORS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED;

EID: 78651287538     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.528114     Document Type: Article

References (15)

1. Addison T. On the constitutional and local effects of disease of the suprarenal capsules. In: A collection of the published writings of the late Thomas Addison MD, Physician to Guy's Hospital. London: New Sydenham Society, Reprinted in Medical Clas sics 19392:244-293;1868.
2. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: Autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocrine Rev. 2002;23: 327-364.
3. Husebye E, Løvås K. Pathogenesis of primary adrenal insufficiency. Best Pract Res Clin Endocrinol Metab. 2009;23: 147-157.
4. Tsatmali M, Ancans J, Yukitake J. Skin POMC peptides: Their actions at the human MC-1 receptor and roles in the tanning response. Pigment Cell Res. 2000;13:125-129.
5. Nussbaum J, Garcia RK. Restorative physical and occupational therapy: A critical need for patients with chronic kidney and end-stage renal disease. Adv Chronic Kidney Dis. 2009;16: 529-535.
6. Nieman LK, Chanco Turner ML. Addison's disease. Clin Der-matol. 2006;24:276-280.
7. Moon SJ, Kim DK, Chang JH, et al. The impact of dialysis modality on skin hyperpigmentation in hemodialysis patients. Nephrol Dial Transplant. 2009;24:2803-2809.
8. Nieman LK. Dynamic evaluation of adrenal hypofunction. J Endocrinol Invest. 2003;267:74-82.
9. Clodi M, Riedl M, Schmaldienst S. Adrenal function in patients with chronic renal failure. Am J Kidney Dis. 1998;32: 52-5.
10. Kelestimur F. The endocrinology of adrenal tuberculosis: The effects of tuberculosis on the hypothalamo-pituitary-adrenal axis and adrenocortical function. J Endocrinol Invest. 2004;27: 380-386.
11. Ma ES, Yang ZG, Li Y. Tuberculous Addison's disease: Mor phological and quantitative evaluation with multidetector-row CT. Eur J Radiol. 2007;62:352-358.
12. Myhre AG, Aarsetøy H, Undlien DE, et al. High frequency of coeliac disease among patients with autoimmune adrenocorti-cal failure. Scand J Gastroenterol. 2003;38:511-515.
13. Peterson P, Uibo R, Krohn KJ. Adrenal autoimmunity: Results and developments. Trends Endocrinol Metab. 2000;11:285-290.
14. Martín Martorell P, Roep BO, Smit JW. Autoimmunity in Addison's disease. Neth Med J. 2002;60:269-75.
15. Betterle C, Dalpra C, Greggio N. Autoimmunity in isolated Addison's disease and in polyglandular autoimmune diseases type 1, 2 and 4. Ann Endocrinol. 2001;62:193-201.